An international team led by researchers at Hiroshima University has developed a new way to detect subtle, early-stage ...
Recently, a pharmaceutical company came to the antibody-discovery specialist, Abveris, with a serious problem. The pharmaceutical company had tried and failed to develop a monoclonal antibody for an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results